Oncternal Therapeutics Inc Defensive Interval Ratio
Oncternal Therapeutics Inc defensive interval ratio. Oncternal Therapeutics Inc (ONCT) has a Defensive Interval Ratio of 104 days as of September 2024. Defensive assets of $1.84 Million (cash $-, short-term investments $1.50 Million, receivables $344.00K) cover 104 days of daily cash needs of $17.68K/day. See Oncternal Therapeutics Inc (ONCT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Oncternal Therapeutics Inc (2003–2023)
Defensive interval ratio of Oncternal Therapeutics Inc from 2003 to 2023. This chart shows how Oncternal Therapeutics Inc's Defensive Interval Ratio has evolved across 18 annual periods from 2003 to 2023. As of September 2024, the ratio stands at 104 days, meaning defensive assets of $1.84 Million can fund 104 days of operations without new revenue. Check Oncternal Therapeutics Inc (ONCT) asset resilience to evaluate the company's liquid asset resilience ratio.
Oncternal Therapeutics Inc Defensive Interval Ratio by Year (2003–2023)
Oncternal Therapeutics Inc defensive interval ratio by year from 2003 to 2023. The table below presents the year-by-year Defensive Interval Ratio for Oncternal Therapeutics Inc from 2003 to 2023, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of Oncternal Therapeutics Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 1979 days | $28.19 Million | $14.24K/day | $- | $27.56 Million | ▲ +708 days |
| 2022 | 1271 days | $26.76 Million | $21.05K/day | $- | $26.58 Million | ▲ +1208 days |
| 2021 | 63 days | $944.00K | $14.97K/day | $- | $0.00 | ▲ +49 days |
| 2018 | 14 days | $200.00K | $14.27K/day | $- | $200.00K | ▼ -1271 days |
| 2017 | 1285 days | $28.08 Million | $21.85K/day | $- | $28.08 Million | ▲ +259 days |
| 2016 | 1026 days | $12.96 Million | $12.63K/day | $- | $12.96 Million | ▲ +842 days |
| 2015 | 184 days | $15.20 Million | $82.66K/day | $- | $15.20 Million | ▼ -166 days |
| 2014 | 350 days | $31.41 Million | $89.84K/day | $- | $31.41 Million | ▲ +334 days |
| 2013 | 16 days | $200.00K | $12.51K/day | $- | $200.00K | ▼ -294 days |
| 2012 | 310 days | $8.05 Million | $26.01K/day | $- | $8.04 Million | ▼ -392 days |
| 2011 | 701 days | $11.68 Million | $16.65K/day | $- | $10.70 Million | ▲ +623 days |
| 2010 | 78 days | $1.13 Million | $14.53K/day | $- | $450.00K | ▼ -138 days |
| 2009 | 216 days | $9.42 Million | $43.70K/day | $- | $8.82 Million | ▲ +156 days |
| 2008 | 60 days | $3.42 Million | $57.47K/day | $- | $2.16 Million | ▼ -897 days |
| 2007 | 956 days | $50.65 Million | $52.96K/day | $- | $9.81 Million | ▲ +954 days |
| 2006 | 2 days | $61.00K | $28.32K/day | $- | $- | ▼ -7 days |
| 2005 | 9 days | $153.00K | $16.37K/day | $- | $- | ▲ +51 days |
| 2003 | -41 days | $-255.00K | $6.16K/day | $- | $- | — |